Wei Wang

33PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NanomedicineInnate immunityMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Apr 02, 2026
Zoledronic acid enhances the antitumor efficacy of the PSMA CAR-T cells for bone tumors, but impedes the ability to control metastases of prostate cancer in mice.

Dan Li, Xinyu Gu, Jing Li

|Sep 22, 2025
Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant.

Weiqi Hong, Ping Cheng, Jingyun Yang

|Mar 19, 2025
CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses.

Yong Huang, Xiao Yang, Jing Li

|Feb 25, 2025
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants.

Jingyun Yang, Weiqi Hong, Huashan Shi

|Jan 27, 2025
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages.

Jingyun Yang, Xuemei He, Huashan Shi

|Dec 31, 2024
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials.

Jingyun Yang, Weiqi Hong, Huashan Shi

Pageof 6

Frequent Collaborators

16 joint publications

Xiawei Wei

14 joint publications

Guangwen Lu

13 joint publications

Weiqi Hong

8 joint publications

Xiangrong Song